Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NY Providers > Urologists

Dr. Michael A. Palese, MD

Accepting New Patients

(391 Ratings)

Specializes in: Urology (Urinary Tract Disease)

Mount Sinai School of Medicine

Professional interests include: bladder cancer, laser treatment, benign prostatic hyperplasia (enlarged prostate), and more.

110 East 60 Street, 5 Floor
Organization:michael Palese, MD 10022

(212) 241-8833

Dr. Michael A. Palese, MD is an urologist in New York, NY specializing in urology (urinary tract disease). He graduated from Mount Sinai School of Medicine. Dr. Michael A. Palese, MD is affiliated with Mount Sinai Health System.

Office Locations

10 Union Square East Suite 3a
New York, NY 10003

open_in_new

Mount Sinai Health System

110 East 60 Street, 5 Floor
Organization:michael Palese, MD 10022

(212) 241-8833

open_in_new

5 E 98th Street Floor 6
New York, NY 10029

(212) 241-4812

(212) 987-4675

open_in_new

Village of Castorland, NY 10003

open_in_new

Some issues Dr. Michael A. Palese, MD can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

Laparoscopic Surgery

Laparoscopic surgery is a kind of minimally invasive surgery using a thin, narrow tube called a laparoscope. Usually performed on the abdomen or the pelvic region, the surgeon makes a few very small incisions instead of one large one.

During the procedure, the surgeon inserts the laparoscope, which contains a light and camera that allows the surgeon to see what is happening inside the body. Then tiny tools are placed through the small openings and used to perform the surgery.

The most common laparoscopic surgery is gallbladder removal, but laparoscopic surgery may also be used for the removal of a kidney or appendix, to treat certain cysts and tumors, for bariatric surgery, for some GERD treatments, or for hernia repairs, among others.

Because laparoscopic surgery only uses a few tiny incisions, the scars are minimal and recovery is easier than with open surgery.

In The News (see more mentions in the news)

“"If you're dehydrated and are holding onto more of the actual water itself, the urine will become darker and darker," Michael A Palese, M.D., chair of the Department of Urology at Mount Sinai in...”—"Ask a doctor: 'Can I be dehydrated even if I'm not thirsty?'", Yahoo News, August 2024

“Director of minimally invasive surgery at Mount Sinai, Dr. Michael A. Palese has been working as a robotic and laparoscopic surgeon for the past decade.”—"Daily Checkup: New options for the age-old issue of prostate cancer", New York Daily News, September 2013

“The new recommendations are a "radical change," but a welcome one, says Michael Palese, associate professor of urology at the Icahn School of Medicine at Mount Sinai, who was not involved in...”—"Urology group stops recommending routine PSA test", USA Today, May 2013

Noteworthy Medicare Patient Procedures Performed by Dr. Michael A. Palese, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 25%

By Volume:

diagnostic cystoscopy

In 2012, Dr. Michael A. Palese, MD performed more diagnostic cystoscopy procedures for Medicare patients than 75% of providers in related specialties within New York.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2012 were urologic procedures, blood draw, minimally invasive procedures and lab tests.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

abdominal imaging	11
ablation	14
blood draw	249
doctor visit	774
foreign body removal	88
hospital care	136
inpatient care	136
lab tests	160
laser treatment	14
minimally invasive procedures	239
stent placement (stenting)	54
ultrasound (sonogram)	11
urologic procedures	495

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2013 were urologic procedures, blood draw, minimally invasive procedures and inpatient care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

abdominal imaging	11
ablation	11
blood draw	305
catheterization	19
doctor visit	851
foreign body removal	60
hospital care	113
inpatient care	113
lab tests	31
laser treatment	11
minimally invasive procedures	212
stent placement (stenting)	34
suprapubic catheter replacement	55
ultrasound (sonogram)	11
urologic procedures	574

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	417
Female	150

**Ethnicity**
Non-Hispanic White	335
Black	100
Hispanic	81
Asian	29
Other	22
Native American	0

**Age**
From 65 to 74	248
From 75 to 84	151
85 and over	51
Less than 65	117

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2013

Hypertension	71
High Cholesterol	60
Stroke	5
Ischemic Heart Disease	49
Depression	19
Chronic Kidney Disease	58
Asthma	9
Osteoperosis	7
Atrial Fibrilation	9
Heart Failure	27
Chronic Obstructive Pulmonary Disease	12
Diabetes	43
Dementia	9
Cancer	19

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2014 were urologic procedures, blood draw, minimally invasive procedures and inpatient care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

abdominal imaging	13
ablation	11
blood draw	328
catheterization	17
doctor visit	925
foreign body removal	99
hospital care	142
inpatient care	142
laser treatment	18
lithotripsy (stone fragmentation)	29
minimally invasive procedures	296
stent placement (stenting)	63
suprapubic catheter replacement	79
ultrasound (sonogram)	13
urologic procedures	703

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	430
Female	190

**Ethnicity**
Non-Hispanic White	350
Black	120
Hispanic	95
Asian	29
Other	26
Native American	0

**Age**
From 65 to 74	286
From 75 to 84	168
85 and over	46
Less than 65	120

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2014

Hypertension	73
High Cholesterol	64
Stroke	4
Ischemic Heart Disease	47
Depression	17
Chronic Kidney Disease	58
Asthma	9
Osteoperosis	8
Atrial Fibrilation	10
Heart Failure	28
Chronic Obstructive Pulmonary Disease	11
Diabetes	42
Dementia	9
Cancer	16

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2015 were urologic procedures, blood draw, minimally invasive procedures and hospital care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

abdominal imaging	15
ablation	18
blood draw	291
doctor visit	890
foreign body removal	36
hormone therapy	29
hospital care	125
inpatient care	125
minimally invasive procedures	193
stent placement (stenting)	24
ultrasound (sonogram)	15
urologic procedures	593

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	878
Female	274

**Ethnicity**
Non-Hispanic White	712
Black	180
Hispanic	140
Asian	44
Other	76
Native American	0

**Age**
From 65 to 74	572
From 75 to 84	320
85 and over	72
Less than 65	188

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2015

Hypertension	72
High Cholesterol	61
Stroke	5
Ischemic Heart Disease	42
Depression	18
Chronic Kidney Disease	51
Asthma	10
Osteoperosis	6
Atrial Fibrilation	10
Heart Failure	22
Chronic Obstructive Pulmonary Disease	10
Diabetes	41
Dementia	7
Cancer	19

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2016 were urologic procedures, minimally invasive procedures, blood draw and hospital care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

abdominal imaging	17
blood draw	165
doctor visit	732
foreign body removal	25
hospital care	94
inpatient care	94
minimally invasive procedures	196
stent placement (stenting)	22
ultrasound (sonogram)	17
urologic procedures	484

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	385
Female	123

**Ethnicity**
Non-Hispanic White	350
Black	63
Hispanic	50
Asian	12
Other	33
Native American	0

**Age**
From 65 to 74	242
From 75 to 84	155
85 and over	47
Less than 65	64

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2016

Hypertension	67
High Cholesterol	58
Stroke	5
Ischemic Heart Disease	45
Depression	17
Chronic Kidney Disease	51
Asthma	15
Osteoperosis	7
Atrial Fibrilation	12
Heart Failure	21
Chronic Obstructive Pulmonary Disease	11
Diabetes	34
Dementia	9
Cancer	20

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2017 were urologic procedures, minimally invasive procedures, blood draw and hospital care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

abdominal surgery	11
ablation	28
blood draw	62
doctor visit	799
foreign body removal	16
hospital care	45
inpatient care	45
lithotripsy (stone fragmentation)	15
minimally invasive procedures	230
open surgery	11
removal of internal scar tissue	11
stent placement (stenting)	28
urologic procedures	572

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	392
Female	119

**Ethnicity**
Non-Hispanic White	355
Black	65
Hispanic	41
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	256
From 75 to 84	161
85 and over	39
Less than 65	55

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2017

Hypertension	67
High Cholesterol	50
Stroke	3
Ischemic Heart Disease	44
Depression	16
Chronic Kidney Disease	49
Asthma	6
Osteoperosis	5
Atrial Fibrilation	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	34
Dementia	6
Cancer	20

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2018 were urologic procedures, minimally invasive procedures, stent placement (stenting) and hospital care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

doctor visit	705
foreign body removal	11
hospital care	47
inpatient care	47
laser treatment	15
lithotripsy (stone fragmentation)	15
minimally invasive procedures	203
stent placement (stenting)	57
urologic procedures	503

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	378
Female	117

**Ethnicity**
Non-Hispanic White	359
Black	50
Hispanic	42
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	248
From 75 to 84	160
85 and over	51
Less than 65	36

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2018

Hypertension	65
High Cholesterol	59
Stroke	5
Ischemic Heart Disease	44
Depression	15
Chronic Kidney Disease	54
Asthma	7
Osteoperosis	8
Atrial Fibrilation	11
Heart Failure	18
Chronic Obstructive Pulmonary Disease	11
Diabetes	34
Dementia	8
Cancer	17

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2019 were urologic procedures, minimally invasive procedures, stent placement (stenting) and ablation.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

ablation	22
catheterization	21
doctor visit	883
foreign body removal	17
lithotripsy (stone fragmentation)	14
minimally invasive procedures	240
stent placement (stenting)	39
urologic procedures	477

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	408
Female	130

**Ethnicity**
Non-Hispanic White	382
Black	52
Hispanic	42
Asian	16
Other	46
Native American	0

**Age**
From 65 to 74	259
From 75 to 84	185
85 and over	51
Less than 65	43

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2019

Hypertension	67
High Cholesterol	61
Stroke	4
Ischemic Heart Disease	47
Depression	18
Chronic Kidney Disease	50
Asthma	6
Osteoperosis	7
Atrial Fibrilation	10
Heart Failure	18
Chronic Obstructive Pulmonary Disease	12
Diabetes	32
Dementia	8
Cancer	17

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2020 were urologic procedures, minimally invasive procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

ablation	21
diagnostic procedures	13
doctor visit	750
foreign body removal	28
hospital care	78
inpatient care	78
minimally invasive procedures	209
minor procedures	13
stent placement (stenting)	20
urologic procedures	341

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	428
Female	121

**Ethnicity**
Non-Hispanic White	373
Black	51
Hispanic	56
Asian	20
Other	49
Native American	0

**Age**
From 65 to 74	249
From 75 to 84	191
85 and over	62
Less than 65	47

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2020

Hypertension	62
High Cholesterol	55
Stroke	4
Ischemic Heart Disease	45
Depression	16
Chronic Kidney Disease	50
Asthma	8
Osteoperosis	7
Atrial Fibrilation	9
Heart Failure	19
Chronic Obstructive Pulmonary Disease	10
Diabetes	31
Dementia	10
Cancer	19

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2021 were urologic procedures, minimally invasive procedures, blood draw and hospital care.

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

ablation	21
blood draw	103
doctor visit	706
foreign body removal	12
hospital care	58
inpatient care	58
laser treatment	14
lithotripsy (stone fragmentation)	14
minimally invasive procedures	186
stent placement (stenting)	14
urologic procedures	332

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	431
Female	119

**Ethnicity**
Non-Hispanic White	385
Black	51
Hispanic	45
Asian	22
Other	47
Native American	0

**Age**
From 65 to 74	253
From 75 to 84	193
85 and over	66
Less than 65	38

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2021

Hypertension	68
High Cholesterol	64
Stroke	5
Ischemic Heart Disease	42
Depression	17
Chronic Kidney Disease	45
Asthma	7
Osteoperosis	6
Atrial Fibrilation	10
Heart Failure	17
Chronic Obstructive Pulmonary Disease	10
Diabetes	33
Dementia	9
Cancer	20

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY during 2022 were urologic procedures, minimally invasive procedures, blood draw and stent placement (stenting).

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

ablation	18
blood draw	121
doctor visit	822
foreign body removal	11
minimally invasive procedures	182
stent placement (stenting)	19
urologic procedures	331

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Male	467
Female	111

**Ethnicity**
Non-Hispanic White	420
Black	41
Hispanic	45
Asian	17
Other	55
Native American	0

**Age**
From 65 to 74	237
From 75 to 84	256
85 and over	51
Less than 65	34

Conditions of Medicare patients treated by Dr. Michael A. Palese, MD in 2022

Hypertension	75
High Cholesterol	75
Stroke	9
Ischemic Heart Disease	33
Depression	16
Chronic Kidney Disease	25
Asthma	7
Osteoperosis	11
Atrial Fibrilation	16
Heart Failure	12
Chronic Obstructive Pulmonary Disease	11
Diabetes	30
Dementia	6
Cancer	32

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Michael A. Palese, MD for Medicare patients.

The highest averages for the top procedures that Dr. Michael A. Palese, MD treated as an urologist in New York, NY were urologic procedures, minimally invasive procedures, blood draw and lab tests.

abdominal imaging	13
abdominal surgery	11
ablation	18
blood draw	203
catheterization	19
diagnostic procedures	13
doctor visit	803
foreign body removal	36
hormone therapy	29
hospital care	93
inpatient care	93
lab tests	95
laser treatment	14
lithotripsy (stone fragmentation)	17
minimally invasive procedures	216
minor procedures	13
open surgery	11
removal of internal scar tissue	11
stent placement (stenting)	34
ultrasound (sonogram)	13
urologic procedures	491

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Michael A. Palese, MD.

**Gender**
Female	132
Male	419

**Ethnicity**
Black / African American	70
Asian / Pacific Islander	17
Non-Hispanic White	365
Hispanic	57
Native American / Alaskan Native	0
Other	32

**Age**
85 and over	48
75 to 84	176
Less than 65	67
65 to 74	259

Average of Total of Conditions of Medicare patients treated by Dr. Michael A. Palese, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Michael A. Palese, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	62
High Cholesterol	55
Stroke	4
Ischemic Heart Disease	39
Depression	15
Chronic Kidney Disease	44
Asthma	7
Osteoporosis	6
Heart Failure	18
Chronic Obstructive Pulmonary Disease	10
Diabetes	32
Atrial Fibrillation	9
Dementia	7
Cancer	18

Education & Training

Dr. Michael A. Palese, MD graduated from Mount Sinai School of Medicine. He completed residency at University of Maryland Medical Center. He is certified by the American Board of Urology and has a state license in New York.

Medical School: Mount Sinai School of Medicine

Residency: University of Maryland Medical Center

Board Certification: American Board of Urology

Licensed In: New York

Affiliations & Hospitals

Dr. Michael A. Palese, MD is associated with these hospitals and organizations:

Mount Sinai Health System

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Michael A. Palese, MD appears to accept the following insurance providers: Horizon Blue Cross Blue Shield, MagnaCare, EmblemHealth, Oscar, Healthfirst Medicaid, United Healthcare, Medicaid, Cigna, 1199SEIU, Healthfirst Medicare, Private Healthcare Systems (PHCS), Group Health Incorporated (GHI), Centivo, Medicare - NY, AETNA - Medicare, Oxford - Freedom and Liberty, Medicare - NJ, AETNA - Commercial, VNSNY Choice Medicare and VillageCareMax.

Insurance Accepted by Provider includes:

According to our sources, Dr. Michael A. Palese, MD accepts the following insurance providers:

Horizon Blue Cross Blue Shield

MagnaCare

EmblemHealth

Oscar

Healthfirst Medicaid

United Healthcare

Medicaid

Cigna

1199SEIU

Healthfirst Medicare

Private Healthcare Systems (PHCS)

Group Health Incorporated (GHI)

Centivo

Medicare - NY

AETNA - Medicare

Oxford - Freedom and Liberty

Medicare - NJ

AETNA - Commercial

VNSNY Choice Medicare

VillageCareMax

Ratings & Reviews

Dr. Michael A. Palese, MD has an exceptional overall rating with an average of 4.9 out of 5 stars based on 391 ratings. We collect ratings and reviews of Dr. Michael A. Palese, MD from all over the web to help you find the right in New York, NY.

4.9

Overall Rating

(391 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Michael A. Palese, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Bard International, Inc.	$38,369 Vascular $38,369
Boston Scientific Corporation	$19,137 rezum Generator $11,046	GENERAL KIDNEY STONE DISEASE $1,742	GENERAL - KIDNEY STONE DISEASE $1,376	General - BPH $960	SpaceOAR VUE System - 10mL $831	Other $3,181
C. R. Bard, Inc. & Subsidiaries	$16,024 BMD-Solo Guidewire $4,818	BMD-Dual Lumen Ureteral Catheter $3,743	BMD-Bard Skylite $1,311	Urology $773	BMD-Inlay Optima Ureteral Stent $100	Other $5,279
Intuitive Surgical, Inc.	$8,523 Da Vinci Surgical System $8,523
Ambu Inc.	$4,761 $4,761
Other	$18,429 DERMACELL $4,417	SUTENT $4,000	1588 HD 3 Chip Camera $1,576	Myrbetriq $835	XTANDI $585	Other $7,015

**Types of Payments**
Travel and Lodging	$32,496
Honoraria	$28,749
Food and Beverage	$15,541
Consulting Fee	$15,455
Education	$6,751
Other	$6,250

Biography

Dr. Michael Palese's area of specialization is urology (urinary tract disease). In addition to English, Dr. Palese (or staff) speaks Spanish, German, and French. Dr. Palese's areas of expertise include the following: bladder cancer, robotic kidney surgery, and polycystic kidney disease. He is professionally affiliated with Mount Sinai Beth Israel, Mount Sinai West, and Mount Sinai Brooklyn. After attending Mount Sinai School of Medicine, Dr. Palese completed his residency training at the University of Maryland Medical Center. Patients gave him an average rating of 5.0 stars (out of 5). Medicaid Managed Care, Blue California, and Healthfirst are among the insurance carriers that Dr. Palese honors. His distinctions include: New York Super Doctors; Best Video/Multispecialty, Society of Lapaoendoscopic Surgeons (SLS); and Best Video/Urology, Society Of Laparoendoscopic Surgeons (SLS). According to Mount Sinai Health System, he is currently accepting new patients at his office in Village of Castorland, NY.